Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (49)Imfinzi+Imjudo improves PFS in early liver cancer
Preheader (150)Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-fr
Typography
Arial
Colors
Text Analysis
Body Words165
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px840 px
X-Spam Score1.5
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEarly Morning

Imfinzi+Imjudo improves PFS in early liver cancer

Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-fr
Imfinzi+Imjudo improves PFS in early liver cancer